FDA will not subject device data systems to premarket approval

02/14/2011 | Health Data Management

The FDA is set to unveil today the final rule that would exempt medical device data systems from premarket approval by reclassifying such devices from the Class III category to Class I. In its final rule, the agency discussed the functions of an MDDS and stated the differences between an MDDS and a patient monitoring system.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA